Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03272880 · ClinicalTrials.gov registry record · NA
Utilizing the Arts to Improve Health, Resilience, and Well-Being Among Cancer Patients and Their Caregivers
A NA study, sponsored by Case Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT03272880: Completed NA study, sponsored by Case Comprehensive Cancer Center.
NCT03272880 is a NA study that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03272880, a NA study, has completed, sponsored by Case Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the impact of arts-based programming on health, well-being, and resilience. Patients who have cancer or are the caregivers of someone with cancer are being asked to take part in this study.
Primary Outcome
Study will be feasible if recruitment goal is met with 10-20 participants enrolled
Interventions
- BEHAVIORAL Arts-Based Programming
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2017-09-25 |
| Est. Completion | 2018-04-13 |
| Phase | NA |
What the finished NCT03272880 record still lists
NCT03272880 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Arts-Based Programming is the first listed.
NCT03272880 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03272880 about?
NCT03272880 is a clinical study titled "Utilizing the Arts to Improve Health, Resilience, and Well-Being Among Cancer Patients and Their Caregivers". The purpose of this study is to evaluate the impact of arts-based programming on health, well-being, and resilience. Patients who have cancer or are the caregivers of someone with cancer are being asked to take part in this study.
What is the current status of trial NCT03272880?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2017-09-25. Estimated completion is 2018-04-13.
What interventions are being tested in trial NCT03272880?
The interventions under investigation include: Arts-Based Programming (BEHAVIORAL).
Who is sponsoring clinical trial NCT03272880?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03272880's enrollment target sits among peer trials
6 1983rd of 2000 higher than 13 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI